000 | 01818 a2200469 4500 | ||
---|---|---|---|
005 | 20250518091025.0 | ||
264 | 0 | _c20210111 | |
008 | 202101s 0 0 eng d | ||
022 | _a1478-6362 | ||
024 | 7 |
_a10.1186/s13075-020-2126-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMease, Philip | |
245 | 0 | 0 |
_aInhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial. _h[electronic resource] |
260 |
_bArthritis research & therapy _c03 2020 |
||
300 |
_a43 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
650 | 0 | 4 |
_aArthritis, Psoriatic _xdiagnostic imaging |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHand Joints _xdiagnostic imaging |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aRadiography _xmethods |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aHusni, M Elaine | |
700 | 1 | _aKafka, Shelly | |
700 | 1 | _aChakravarty, Soumya D | |
700 | 1 | _aHarrison, Diane D | |
700 | 1 | _aLo, Kim Hung | |
700 | 1 | _aXu, Stephen | |
700 | 1 | _aHsia, Elizabeth C | |
700 | 1 | _aKavanaugh, Arthur | |
773 | 0 |
_tArthritis research & therapy _gvol. 22 _gno. 1 _gp. 43 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13075-020-2126-1 _zAvailable from publisher's website |
999 |
_c30714302 _d30714302 |